Sep.04 -- Nithya Balasubramanian, healthcare analyst for India at Bernstein, explains why she expects an approved vaccine to be in the market in early 2021, and the outlook for the country's pharmaceutical industry. She speaks with Haslinda Amin and Rishaad Salamat on "Bloomberg Markets: Asia."
View on YouTube
No comments:
Post a Comment